VIDEO: What is considered good vaccine efficacy?
DHVI Investigator and director of the Duke CIVICs Vaccine Center (DCVC), Dr. Tony Moody answers questions about effectiveness of the Moderna, Pfizer and Johnson & Johnson vaccines. Dr. Moody is a Professor of Pediatrics at Duke and an experienced clinician in Pediatric Infectious Diseases.
Advancing Women In Science Mentoring Event
Duke faculty, staff and students attended the Advancing Women In Science Mentoring Event with guest speaker Dr. Carolyn Coyne. Dr. Coyne is a professor at the University of Pittsburgh School of Medicine and Director of the Center for Microbial Pathogenesis.
COVID: Uncovered - 1/20/21
A few takeaways from DHVI director, Dr. Bart Haynes' interview with PBS North Carolina on COVID-19 vaccines.
DHVI Faculty Opinion: Why are some healthcare workers denying COVID-19 vaccination?
The Pfizer and Moderna vaccines have proven to be highly effective in preventing severe cases of COVID-19 with over 94% protection against SAR-CoV-2. Although expedited, the vaccines were carefully evaluated in clinical trials and were approved by the Emergency Use Authorization (EUA) by the Federal Drug Administration (FDA) in December 2020.
Eight School scientists make Cell Mentor's 1,000 Inspiring Black Scientists list
Thirteen Duke scientists, including eight members of the Duke University School of Medicine, appeared in a new list of 1,000 inspiring Black scientists in the United States. Cell Mentor, a blog and online resource for researchers, composed the list to showcase the contributions Black scientists make to the scientific community.
A New Vaccine to Battle Covid-19
The United States and many parts of the world have now lost control of the Covid-19 pandemic owing to the respiratory spread of SARS-CoV-2 and to inconsistent adherence to effective public health measures, including wearing masks and maintaining social distancing. Persons infected with SARS-CoV-2 are frequently asymptomatic, yet they have high respiratory viral loads, and they are major purveyors of viral spread.
Barton Haynes Answers the Essential Questions About the COVID Vaccine
Dr. Barton Haynes talked about the many continuing questions researchers still have about the COVID-19 virus and why Americans should have confidence in the safety and durability of the vaccine.
Duke Human Vaccine Institute-IVQAC IVQAC Laboratory Receives Accreditation from College of American Pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Duke Human Vaccine Inst- IVQAC IVQAC Laboratory, Durham, North Carolina based on results of a recent on-site inspection as part of the CAP's Accreditation Programs.
Here's what you need to know about getting the Covid-19 vaccine
CNN's Brian Todd reports on what we need to know about the safety, side effects and timelines of the Covid-19 vaccine.
Vaccine Distribution: Opportunities and Pitfalls
The recent, well-publicized success of two COVID-19 vaccines offers a glimmer of hope in a year of darkness for so many. As the U.S. and nations everywhere scramble to figure out the logistics of getting the vaccine out broadly, four Duke experts Thursday discussed the various hurdles involved.